Wang, W.; Zuo, B.; Wang, Y.; Li, X.; Weng, Z.; Zhai, J.; Wu, Q.; He, Y.
Megakaryocyte- and Platelet-Derived Microparticles as Novel Diagnostic and Prognostic Biomarkers for Immune Thrombocytopenia. J. Clin. Med. 2022, 11, 6776.
https://doi.org/10.3390/jcm11226776
AMA Style
Wang W, Zuo B, Wang Y, Li X, Weng Z, Zhai J, Wu Q, He Y.
Megakaryocyte- and Platelet-Derived Microparticles as Novel Diagnostic and Prognostic Biomarkers for Immune Thrombocytopenia. Journal of Clinical Medicine. 2022; 11(22):6776.
https://doi.org/10.3390/jcm11226776
Chicago/Turabian Style
Wang, Wen, Bin Zuo, Yao Wang, Xinyu Li, Zhen Weng, Juping Zhai, Qingyu Wu, and Yang He.
2022. "Megakaryocyte- and Platelet-Derived Microparticles as Novel Diagnostic and Prognostic Biomarkers for Immune Thrombocytopenia" Journal of Clinical Medicine 11, no. 22: 6776.
https://doi.org/10.3390/jcm11226776
APA Style
Wang, W., Zuo, B., Wang, Y., Li, X., Weng, Z., Zhai, J., Wu, Q., & He, Y.
(2022). Megakaryocyte- and Platelet-Derived Microparticles as Novel Diagnostic and Prognostic Biomarkers for Immune Thrombocytopenia. Journal of Clinical Medicine, 11(22), 6776.
https://doi.org/10.3390/jcm11226776